Английская Википедия:Bartonella henselae
Шаблон:Short description Шаблон:Speciesbox Bartonella henselae, formerly Rochalimæa henselae, is a bacterium that is the causative agent of cat-scratch disease[1] (bartonellosis).
Bartonella henselae is a member of the genus Bartonella, one of the most common types of bacteria in the world.Шаблон:Specify The specific name henselae honors Diane Marie Hensel (b. 1953), a clinical microbiology technologist at University of Oklahoma Health Sciences Center, who collected numerous strains and samples of the infective agent during an outbreak in Oklahoma in 1985.[2] It is a facultative intracellular microbe that targets red blood cells. One study showed it invaded the mature blood cells of humans.[3] It infects the host cell by sticking to it using trimeric autotransporter adhesins.[4] In the United States, about 20,000 cases are diagnosed each year,[5] most under 15 years old. Most often, it is transmitted by scratches or bites from kittens.[6]
Diagnosis
Bartonella henselae is a Gram-negative rod.[4][7] It can be cultured in a lysis-centrifugation blood culture.[8] The presence of bacteria can be detected by Warthin-Starry stain, or by a similar silver stain technique performed on infected tissue. A pan-Bartonella PCR detection is non-invasive and uses blood or biopsies to diagnose.[9]
Symptoms
Bartonella henselae infection can appear up to 10 days after exposure to the microbe. Symptoms start with a papule at the site the microbe entered, followed by lymphadenopathy, usually in the axillary node. Half of patients also get aches, nausea, abdominal pain, and malaise.[10] Many other complications can arise from this infection beyond the typical fever, lymphadenopathy, and general malaise. Immunocompromised people or patients who already have other conditions are at greater risk for further complications. Some cases have been found in children who had previous heart-valve disease; these children got endocarditis from B. henselae infection. Some patients had hepatosplenic involvement, myalgia, and arthritis after exposure to B. henselae.[10] In rare cases, osteomyelitis, an infection in the bone, can be a manifestation of B. henselae.[11]
Treatment
No definite treatment regimen is known for a patient infected with B. henselae. Treatment depends on the wide range of symptoms that present. In most cases, it will resolve on its own in 4–6 weeks.[12] Aminoglycosides in laboratory tests showed some bactericidal activity. Bacteriostatic antibiotics are not able to easily get through to intracellular Bartonella, so they are not recommended. In immunocompromised patients, pain medication is often prescribed. Nodes may need to be aspirated if painful, microabscesses often form, the abscess needs to be aspirated in many places to remove all the exudate. Because of chronic sinus-tract formation risks, the nodes should not be incised to be drained. Azithromycin can be used for lymphadenopathy, which is enlarged or swollen lymph nodes.[10]
See also
References
External links
- Bartonella henselae at NCBI Taxonomy Browser
- Type strain of Bartonella henselae at BacDive, the Bacterial Diversity Metadatabase
Шаблон:Gram-negative bacterial diseases Шаблон:Taxonbar
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite web
- ↑ Cotté, Violaine, et al. "Transmission of Bartonella henselae by Ixodes ricinus." Emerging infectious diseases 14.7 (2008): 1074.
- ↑ 4,0 4,1 Angelakis E, Raoult D. Pathogenicity and treatment of Bartonella infections. Int J Antimicrob Agents 2014;44:16–25.
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ 10,0 10,1 10,2 Mazur-Melewska, Katarzyna, et al. "Cat-scratch disease: a wide spectrum of clinical pictures." Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii 32.3 (2015): 216.
- ↑ Pitassi, Luiza Helena Urso, et al. "Bartonella henselae infects human erythrocytes." Ultrastructural pathology 31.6 (2007): 369–372.
- ↑ Zangwill, Kenneth M., et al. "Cat Scratch Disease in Connecticut—Epidemiology, Risk Factors, and Evaluation of a New Diagnostic Test." New England
